Clinical trials
Screening clinical trials
Below are recruiting screening clinical trials, each written for real people, not researchers. We’re tracking 947 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07225374RecruitingPhase 2
Avelumab after chemotherapy for upper tract urothelial cancer
This trial is for people with upper tract urothelial cancer who have already had surgery and chemotherapy (cisplatin-based). It tests whether continuing with a drug called avelumab (an immunotherapy) can help prevent the cancer from coming back.
Seoul, GangnamAges 20 years+ - NCT07198152Recruiting
AI helping find adrenal nodules on chest CT scans
This study is testing whether artificial intelligence (AI) can help find adrenal nodules (small growths on your adrenal glands) by looking at chest CT scans from routine physical exams. If you've had a recent chest CT, this could help detect these nodules without extra testing.
BeijingAges 18 years+ - NCT07106424Recruiting
Early screening study for multiple gastrointestinal tumors
This study is looking for people aged 40-75 who have never had cancer to participate in early screening for gastrointestinal tumors. The goal is to find cancers early when they are easier to treat.
Jinan, ShandongAges 40–75 - NCT06376097Recruiting
Lung cancer screening with low-dose CT and a blood test
This study tests a lung cancer screening program using low-dose CT scans and a blood test to find cancer early. It is for people who smoke or used to smoke.
Botucatu, São PauloAges 45–74 - NCT07650136Recruiting
Testing a New Fingerprint-Based Drug Screening Method
This study compares a new fingerprint-based drug screening system to standard methods. Healthy volunteers will participate to help verify that the new fingerprint test works accurately for detecting drugs.
Marlton, New JerseyAges 18–65 - NCT03689595Enrolling by invitation
PROMISE study: Predicting myeloma risk in high-risk groups
This study uses a blood test to find early signs of myeloma in people at higher risk, such as those with a family history or African ancestry. It aims to predict who might develop myeloma before symptoms appear.
Boston, MassachusettsAges 30 years+ - NCT05625659Recruiting
Breast cancer screening for dense breasts using new X-ray scans
This trial compares two imaging tests—CESM (a contrast-enhanced mammogram) and DBT (3D mammography)—to see which works best for women with dense breast tissue. It may help improve how early breast changes are found in dense breasts.
Birmingham, AlabamaAges 45–74 - NCT06560463Recruiting
CGM and glucose test for cystic fibrosis related diabetes
This study tests if a continuous glucose monitor (CGM) along with a standard glucose drink test can better detect diabetes in people with cystic fibrosis. It is for adults who do not yet have diabetes and are generally healthy.
Milwaukee, WisconsinAges 18 years+ - NCT07736872Recruiting
Sleep apnea screening in diverse groups
This study is screening people from different backgrounds for obstructive sleep apnea (a condition where breathing stops and starts during sleep). It uses a sleep test and questionnaires to see if you might have it.
Guangzhou, GuangdongAges 18–80 - NCT07712107Recruiting
Gastrointestinal Cancer Screening Study Using Combined Detection
This study tests a new way to screen for stomach and digestive cancers using a combination of tests. It compares different screening plans to see which works best for people in their middle years.
Zhaoqing, GuangdongAges 45–74 - NCT03877796Recruiting
Pre-screening study for ovarian cancer after platinum treatment
This trial is a pre-screening process for people with ovarian cancer whose disease came back quickly after platinum chemotherapy (or who cannot take platinum). It may help match you to future study options using a tumor tissue sample.
Tampa, FloridaAges 18 years+ - NCT00246857Recruiting
Screening study for inherited immune system conditions
This study screens people who may have an inherited immune system condition (like problems with immune cell growth or death) and their blood relatives. The goal is to understand the condition better by collecting blood samples for testing.
Bethesda, MarylandAges 1 month–100 years - NCT06604130Enrolling by invitation
Prostate cancer diagnosis using blood exosomes
This study explores whether a simple blood test that looks at tiny particles called exosomes can help diagnose prostate cancer, possibly reducing the need for biopsies. If you have higher PSA levels and are scheduled for a biopsy, this trial might be a fit.
Lanzhou, GansuAges 18 years+ - NCT07731334Recruiting
Memory problems in non-neurology rehab patients
This study looks at how common mild cognitive impairment and dementia are in people staying in rehabilitation units for heart, lung, or orthopedic problems. It aims to understand memory and thinking issues that may be overlooked in these settings.
Florence, FIAges 45 years+ - NCT07453459Recruiting
HPV self-test kit for cervical cancer screening
This trial tests whether giving women a self-collection kit to test for HPV at home can help catch cervical cancer early. It is for people who are overdue for screening and have access to a smartphone and the internet.
St Louis, MissouriAges 25 years+ - NCT07728123Recruiting
Screen2Prevent for young people in the ED
This trial is testing a prevention strategy for young people who come to the emergency department. It aims to find better ways to screen and prevent health problems early on.
Tampa, FloridaAges 14–24 - NCT07671209Recruiting
Cancer care support for patients with leukemia
This trial studies how screening for social needs (like housing, food, or transportation) and offering early help can improve care for adults with leukemia. It is for patients newly referred to a leukemia clinic.
Boston, MassachusettsAges 18 years+ - NCT04045470Recruiting
Skin-device test to find drugs for T-cell lymphoma lesions
This trial tests a tiny device placed directly into skin lymphoma spots to help identify which “candidate” drugs could work. It’s mainly aimed at people with measurable skin involvement from T-cell lymphoma, after they stop certain treatments for a set time.
Boston, MassachusettsAges 18 years+ - NCT07177352RecruitingPhase 3
Screening for Roche Alzheimer's studies
This is a screening study to find people who might be eligible for other Alzheimer's drug studies run by the same company. It helps match you to a treatment trial if you qualify.
Birmingham, AlabamaAges 50–90 - NCT05684692RecruitingPhase 2
Pain-relief study for adults with schwannomatosis
This Phase 2 study tests whether an antibody medicine (either siltuximab or erenumab) can reduce moderate-to-severe pain in adults with schwannomatosis. It compares the medicine to a placebo and looks for improved pain control and tolerability.
Boston, MassachusettsAges 18 years+ - NCT06412029Enrolling by invitation
Improving social needs screening in community cancer clinics
This study aims to help community cancer clinics find better ways to ask patients about their social needs, like food, housing, or transportation. Researchers will work with clinic staff and patients to improve how these screenings happen.
Newark, DelawareAges 18 years+ - NCT07176000Recruiting
Lung Cancer Screening Help for Tribal Communities
This study is testing whether a special patient navigator can help more people in tribal communities get screened for lung cancer. If you are a current or recent smoker between 50 and 77, you may be able to join and get support to find out if you need a lung scan.
Auburn, WashingtonAges 18 years+ - NCT07527871Enrolling by invitation
Emergency care screening and counseling for substance use prevention
This study tests whether screening patients in the emergency department for substance use, followed by a brief counseling session, can help prevent substance use problems and overdoses. You would be asked about your substance use and receive supportive counseling by phone or video.
Columbus, OhioAges 18 years+ - NCT06755632Recruiting
Hepatic fibrosis or cirrhosis screening trial
This trial screens for liver scarring (fibrosis) or severe scarring (cirrhosis) caused by hepatitis B or C. It aims to find people who may benefit from further care or treatment.
BobignyAges 18 years+
Hear when a new Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for screening?
- Yes. Clin2 currently lists 947 recruiting screening studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a screening trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a screening trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.